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InternationalAbstract Purpose: Anterior chamber depth (ACD) is an important preoperative parameter in
anterior segment surgery. Several factors are known to inﬂuence ACD, including race and geogra-
phy. Our purpose was to sample data from various countries to characterize differences in ACD
worldwide and, if any, assess their level of clinical signiﬁcance.
Setting: International, multicenter.
Methods: Cross-sectional study. Using the Pentacam Eye Scanner (OCULUS GmbH, Wetzlar,
Germany), we analyzed ACD measurements from 1077 eyes of 568 normal adults from nine coun-
tries spanning six continents. Differences between countries were assessed by comparison of 95%
conﬁdence intervals and by ANOVA. Normative thresholds were constructed at three standard
deviations (SD) above and below the mean.
Results: Mean ACD was 3.11 mm overall, ranging from 2.91 mm (New Zealand) to 3.24 mm (Uni-
ted States). The ACD among New Zealanders was signiﬁcantly shallower (P< .0001) than that
among Chinese, Egyptians, Germans, Indians, and Americans. The maximum difference in the
mean ACDs was 0.33 mm, between New Zealand and the United States. The shallowest 0.15%
of normal ACD values occurred below 2.04 mm overall, ranging from 1.69 mm (New Zealand)
to 2.42 mm (United States). The deepest 0.15% of normal ACD values occurred above 4.18 mm
overall, ranging from 4.03 mm (Saudi Arabia) to 4.35 mm (Brazil).
Conclusions: ACD did not vary signiﬁcantly in the countries studied, with the notable exception of
New Zealand. Surgeons should anticipate a greater likelihood of a shallow ACD when evaluating
patients from New Zealand. Clinical examination and direct measurement of ACD are recom-
mended. Finally, deep ACD has limited clinical utility in screening for keratoconus.
ª 2011 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Anterior chamber depth (ACD) is an established anterior seg-
ment biometric parameter. Anatomically, it represents the dis-
tance between the corneal endothelium and the anterior
capsule of the crystalline lens. Clinically, ACD carries preoper-
ative importance for intraocular surgery. For example, cata-
ract surgeons rely on biometric intraocular lens (IOL) power
formulas, the latest generations of which increasingly respect
the role of preoperative ACD measurement (Lee et al.,
2008). Forty-two percent of refractive error after IOL implan-
tation may be attributed to inaccuracy in ACD measurement,
more than from axial length (36%) or corneal power (22%; Ol-
sen, 2007). When ACD is shallow, surgeons must also antici-
pate an increased risk of corneal endothelial injury during
routine cataract extraction. Similarly, safe implantation of
phakic intraocular lenses requires adequate ACD.
The construction of normal reference ranges for ACD is
challenging due to the contributions of multiple variables.
ACD is inﬂuenced by gender and negatively correlated with
age (Casson, 2008; Edmonds et al., 2009; Rabsilber et al.,
2006), while the effect of refractive error has been less consis-
tent (Ucakhan et al., 2008; Utine et al., 2009). ACD also is an
inheritable trait affected by race (Casson, 2008; Leung et al.,
2010). Using geography as a proxy for race, one can appreciate
variations in ACD across many regional studies worldwide
(Alonso et al., 2010; Buehl et al., 2006; Dinc et al., 2010; Doors
et al., 2009; Edmonds et al., 2009; Elbaz et al., 2007; Emre
et al., 2007; Fontes et al., 2010a; Fontes et al., 2010b; Fu
et al., 2010; Huang et al., 2011; Kovacs et al., 2010; Lackner
et al., 2005; Nemeth et al., 2006; Rabsilber et al., 2006; Reu-
land et al., 2007; Salouti et al., 2010; Savant et al., 2008; Su
et al., 2008; Ucakhan et al., 2008; Utine et al., 2009; Wood-mass and Rocha, 2009; Yazici et al., 2010; Yi et al., 2008).
However, a systematic study to examine normal ACD values
and variation across multiple races and countries has not, to
our knowledge, been reported. Furthermore, the United States
Food and Drug Administration (FDA) encourages the collec-
tion of race-speciﬁc data to determine the effectiveness of med-
ical devices (Food and Drug Administration, 2005). Therefore,
we sampled normative data from various countries to test for
signiﬁcant differences in ACD as measured by a rotating Sche-
impﬂug camera.
2. Materials and methods
This was a cross-sectional study conducted at multiple interna-
tional centers. After receiving local Institutional Review Board
exemption at the primary site, de-identiﬁed data were received
from each center. Data consisted of Pentacam Eye Scanner
(OCULUS GmbH, Wetzlar, Germany) examinations of one
or both eyes of adult subjects from Brazil, China, Egypt, Ger-
many, India, Japan, New Zealand, Saudi Arabia, and the Uni-
ted States. Recruited subjects were between the ages of 25–65,
representative of their geographic area, with normal ocular
health by local standard criteria, and with simple myopia,
myopic astigmatism, or emmetropia. Exclusion criteria in-
cluded foreign birth, mixed astigmatism, hyperopia, prior eye
surgery, or personal or family history of corneal ectatic
disease.
We analyzed ACD data measured at the corneal apex in all
eyes. Preliminary analysis revealed these data were statistically
similar and highly correlated between the paired right and left
eyes of applicable subjects. Data were normally distributed
whether examining right eyes only, left eyes only, or all eyes.
Subsequently, one-way ANOVA with pairwise Bonferroni
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Statistical signiﬁcance was set at P< .05. Conﬁdence intervals
(CI) were calculated at the standard 95% conﬁdence level. Fi-
nally, normative gates were constructed from these sample
data at three standard deviations (SD) to encompass 99.7%
of normal values.
3. Results
We analyzed 1077 eyes of 568 normal adult subjects represent-
ing nine countries spanning six continents Table 1. ACD did
not differ signiﬁcantly between right eyes, left eyes, and all eyes
in any country (P> .05, two-tailed unpaired t-test). Mean
ACD (95% CI) for all eyes ranged from a low in New Zealand
of 2.91 (2.83–2.98) mm to a high in the United States of 3.24
(3.17–3.31) mm, with a collective mean of 3.11 (3.09–3.14)
mm (all countries; Fig. 1). While Saudi Arabia was not shown
because a small sample size precluded the calculation of a
meaningful 95% CI, Saudi data were included in the collective
analysis.
The only 95% CI without considerable overlap with the
others belonged to New Zealand. Statistical analysis conﬁrmedTable 1 Sample sizes by country.
Country n Right eyes Left eyes All eyes
Brazil 68 62 65 127
China 100 90 89 179
Egypt 75 75 74 149
Germany 66 66 66 132
India 104 104 101 205
Japan 61 46 54 100
New Zealand 56 56 56 112
Saudi Arabia 8 6 7 13
United States 30 30 30 60
All 568 535 542 1077
Figure 1 Estimated population means for anterior chamber depth by
bars indicate 95% conﬁdence intervals for the estimation of each counthat New Zealand was signiﬁcantly different (P< .0001, AN-
OVA), with shallower ACD than China, Egypt, Germany, In-
dia, and the United States (P< .05 each, pairwise post-tests).
The maximum difference in mean ACDs was 0.33 mm, be-
tween New Zealand and the United States. Differences be-
tween New Zealand and Brazil or Japan did not achieve
signiﬁcance. These relationships persisted when examining
right eyes only (P< .0001, ANOVA) and left eyes only
(P= .0019, ANOVA).
To assess the normal spread of ACD in each country, we
calculated 3 SD gates above and below each mean (Fig. 2).
One could expect 99.7% of normal values to fall between these
upper and lower thresholds. The lower threshold, below which
only 0.15% of normal ACD values occur, ranged from a low in
New Zealand of 1.69 mm to a high in the United States of
2.42 mm, with a collective value of 2.04 mm. The upper thresh-
old, above which only 0.15% of normal ACD values occur,
ranged from a low in Saudi Arabia of 4.03 mm to a high in
Brazil of 4.35 mm, with a collective value of 4.18 mm.
4. Discussion
Review of the literature revealed published normal ACD val-
ues from the Pentacam system for Brazil (Alonso et al.,
2010; Fontes et al., 2010a; Fontes et al., 2010b), China (Fu
et al., 2010; Huang et al., 2011), Germany (Rabsilber et al.,
2006; Reuland et al., 2007), and the United States (Edmonds
et al., 2009). Our data agreed with those published values.
Mean ACD (± SD) for Brazil was 3.09 ± 0.42 mm compared
to 3.07 ± 0.42 mm; for China, 3.14 ± 0.31 mm compared to
3.17 ± 0.27; for Germany, 3.15 ± 0.33 compared to
3.10 ± 0.36; and for the United States, 3.24 ± 0.27 compared
to 3.18 ± 0.28. These similarities appear to conﬁrm the nor-
mative validity of these data in these countries.
Unfortunately, historical controls were not available for
Egypt, India, Japan, New Zealand, and Saudi Arabia. Con-
versely, we found published Pentacam-based normal valuescountry. Sample means for ACD in countries with n> 25. Error
try’s true population mean.
Figure 2 Distribution of normal anterior chamber depth by country. Sample means for ACD by country. Error bars indicate ± 3 SD,
encompassing 99.7% of normal subjects.
258 M.T. Feng et al.from countries not examined in this study, such as Turkey
(Dinc et al., 2010; Emre et al., 2007; Ucakhan et al., 2008;
Utine et al., 2009; Yazici et al., 2010), Iran (Salouti et al.,
2010), and Israel (Elbaz et al., 2007) in the Middle East; Hun-
gary (Kovacs et al., 2010; Nemeth et al., 2006), Austria (Buehl
et al., 2006; Lackner et al., 2005), Holland (Doors et al., 2009),
and England (Savant et al., 2008) in Europe; South Korea (Yi
et al., 2008) and Taiwan (Su et al., 2008) in East Asia; and
Canada in North America (Woodmass and Rocha, 2009).
These may suggest future areas for further investigation.
Our data were notable for statistically shallower mean
ACD in New Zealand, the magnitude of which measured up
to 0.33 mm and appeared clinically signiﬁcant (Fig. 1). This re-
sult was surprising, as we expected the shallowest ACD data to
come from East Asia. This result may represent greater heter-
ogeneity in the local population of New Zealand, whether due
to heterogeneity of race or age distribution, for example. Con-
sistent with those possibilities, New Zealand data were among
the most widely spread, as evidenced by a large SD. ACD is
known to decrease with increasing age and (commonly age-re-
lated) cataract size.
Indeed, a weakness of this study is the absence of associated
age, gender, and cataract data. To create a normative data-
base, the study was designed to leave age distribution up to
the local discretion of the recruiting co-investigator. The deﬁ-
nition of a normal subject was left deliberately ambiguous with
regards to non-ocular parameters, such as age, race, and
gender. Co-investigators at each site were given complete
autonomy to determine their local deﬁnition of normal. Never-
theless, supplementation of our ACD data with demographic
data would allow adjustment for age, gender, and presence
of cataract, and would yield more rigorous analysis and con-
clusions, especially when comparing a country with younger
demographics to another with an older population.
We limited our study to myopes and emmetropes as our
database was an extension of prior work which excluded hype-
ropes (Khachikian and Belin, 2009). This study might, there-fore, overestimate mean ACD in regions where hyperopes
constitute a signiﬁcant proportion of the normal population,
given that hyperopes are known to have shallower anterior
chambers. However, the proportion of hyperopes in various
geographic areas is unknown. We also acknowledge that
ACD variation may occur within countries. While our data
are in agreement with available historical controls, sampling
error remains possible without multiple study sites within each
country. Finally, our ﬁndings may be limited to ACD as mea-
sured by Scheimpﬂug imaging. ACD can also be measured by
ultrasound (A-scan, ultrasound biomicroscopy, very high fre-
quency digital ultrasound), partial coherence interferometry,
anterior segment optical coherence tomography, and slit-
scanning videokeratography. Differences have been reported
in ACD measurements between these modalities, some by as
much as 0.17 mm (Lee et al., 2008), which is greater than the
mean differences between most countries examined in this
study.
Several Pentacam-based studies have noted signiﬁcantly
deeper mean ACD in eyes with keratoconus than normal con-
trols. Speciﬁcally, mean ACD in eyes with keratoconus ranged
from 3.29 to 3.34 mm (Edmonds et al., 2009; Kovacs et al.,
2010). In a third study, mean ACD ranged from 3.3 mm in
moderate keratoconus to 3.7 mm in severe disease (Emre
et al., 2007). Our data suggest that these differences, while real,
have limited clinical utility in screening for keratoconus. Col-
lective ACD data from all nine countries yielded a 3 SD upper
threshold of 4.18 mm (Fig. 2). The corresponding 2 SD and 1
SD upper thresholds were 3.83 and 3.47 mm, respectively.
Therefore, the mean ACD for eyes with keratoconus lies well
within 1 SD, and one could expect more 16% of normal eyes
to exceed 3.29–3.34 mm. Furthermore, more than 2.5% of nor-
mal eyes would exceed 3.7 mm without having severe kerato-
conus. Deeper ACD correlated signiﬁcantly with increased
posterior corneal elevation (Kovacs et al., 2010), and we rec-
ommend continued use of the latter for keratoconus screening
(Khachikian and Belin, 2009).
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In summary, it is preferable to establish racial/geographic-spe-
ciﬁc normative values where possible. ACD did not vary
signiﬁcantly in the countries studied, with the notable excep-
tion of New Zealand. Surgeons planning to operate on patients
from New Zealand should anticipate a greater likelihood of a
shallow ACD. Clinical examination and direct measurement of
ACD are recommended. Future studies should examine a
hyperopic population as the dimensions and requirement
for hyperopic phakic IOL’s differ from those for myopia.
Finally, deep ACD has poor clinical utility in screening for
keratoconus.
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